top of page

our products

The information provided below about our products is intended for use by: 

  • people in Australia who have been prescribed a Biocelect product, and 

  • healthcare professionals practicing in Australia

​

For medical enquiries or to report any suspected adverse events please contact us on:

Email: patientsafety@biocelect.com

Phone: +61 1300 848 628

ACARIZAX® (American house dust mite extract and European house dust mite extract)

​

Allergic rhinitis:

ACARIZAX® is indicated for the treatment of house dust mite (HDM) allergic rhinitis not well controlled despite use of symptom relieving medication in adults and adolescents 12 years and over.

​

Allergic asthma:

ACARIZAX® is indicated for the treatment of HDM allergic asthma not well controlled by inhaled corticosteroids and associated with HDM allergic rhinitis in adults. Patients’ asthma status should be carefully evaluated before the initiation of treatment

​

GRAZAX® (Phleum pratense)

​

GRAZAX® is indicated for disease modifying treatment of grass pollen (Phleum pratense or allergens cross reacting with P. pratense) induced allergic rhinitis with or without conjunctivitis in adults, adolescents and children above the age of 5 years.

IMOJEV® (Japanese encephalitis virus [live, attenuated])

​

For prophylaxis of Japanese encephalitis caused by the Japanese encephalitis virus, in individuals from 9 months of age and over.

​

VAXCHORA®  (Vibrio cholerae [live, attenuated])

​

For active immunisation against disease caused by Vibrio cholerae serogroup O1 in adults and children aged 2 years and older travelling to choleraaffected countries.

​

Kodatef®  (tafenoquine succinate)

​

For the prevention of malaria in adults 18 years of age and above for up to 6 months of continuous dosing

Vivotif® Oral (Oral Typhoid Vaccine Salmonella typhi strain Ty21a [live, attenuated])

 

For active immunisation against typhoid in adults and children above 6 years of age.

RAPIVAB™ (peramivir injection)

​

For the treatment of acute influenza infection in adults and children 2 years and older who have been symptomatic for no more than two days

​

STANDARD™  G6PD

​

STANDARD™ G6PD is a semi-quantitative point of care glucose-6-phosphate dehydrogenase (G6PD) enzyme activity testing system.

​

NUVAXOVID™ (SARS-CoV-2 rS [NVX-CoV2373])

​

For information about NUVAXOVID™ COVID-19 vaccine and related medical information enquiries, adverse event reports, and product quality complaints,  please call:
+61 2 7202 1444

Monday – Friday 9:00 to 17:00 AEST/AEDT (except national public holidays)

​

Imojev
Nuvaxovid
Vivotif
Vaxchora
Allergy
Biocelect Logo_Colour.png

© 2025 Biocelect

Product, Medical & Patient Enquiries -  Phone: +61 1300 848 628 Email: patientsafety@biocelect.com

General Enquiries & Ordering Information - Phone: +61 1300 907 411 Email: info@biocelect.com

All phone numbers are free call from Australia & New Zealand 

Australian Office: Level 4, 143 Macquarie Street, Sydney NSW 2000, Australia

Registered Office Australia: Level 29, 66 Goulburn Street, Sydney NSW 2000, Australia

Registered Office New Zealand: Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand

Biocelect acknowledges the Traditional Custodians of Australia and their continued connection to land,
sea and community. We pay our respects to the Elders, emerging, past and present. â€‹

Privacy Policy

Last Updated 21st January 2026

  • linkedin
bottom of page